Literature DB >> 71269

Effect of heat on antigenicity and immunogenicity of the antigenic determinant shared by Haemophilus influenzae type b and Escherichia coli K100.

H Y Whang, J Goldhar, E Neter.   

Abstract

Escherichia coli K100 produces an antigenic determinant similar to, or identical with, the capsular antigen of Haemophilus influenzae type b. Studies of the effects of heat on the immunogenicity, erythrocyte-modifying capacity, and antigenicity of this cross-reacting antigen (CRA) revealed the following findings. Immunization of rabbits with viable or formaldehyde-killed suspensions of E. coli K100, producing CRA, engendered CRA antibodies in significant titers, as demonstrated by hemagglutination of erythrocytes modified by H. influenzae type b antigen. Heating of the suspensions for 1 h at 56 or 100 degrees C destroyed the immunogenicity of CRA, and the heated suspensions did not prime for a secondary antibody response. Supernatants of heated suspensions also were non-immunogenic. Repeated freezing and thawing of heated suspensions of E. coli K100 or their supernatants did not restore immunogenicity. Heat also abolished the immunogenicity of H. influenzae type b. The loss of immunogenicity of CRA of E. coli K100 by heat was not due to alteration of the antigenic determinant, since heated suspensions and supernatants thereof modified erythrocytes for agglutination by H. influenzae type b antiserum. The latter supernatants also inhibited hemagglutination by H. influenzae type b antibodies and absorbed the latter. We conclude that striking differences exist in the effects of heat on CRA on the one hand and of enterobacterial common antigen and lipopolysaccharide O antigen of enteric bacteria on the other. Heating of the latter two antigens does not abolish their priming effect, and repeated freezing and thawing restores the immunogenicity of heated antigens.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 71269      PMCID: PMC421194          DOI: 10.1128/iai.18.1.68-72.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Studies of enterobacterial lipopolysaccharides; effects of heat and chemicals on erythrocyte-modifying, antigenic, toxic and pyrogenic properties.

Authors:  E NETER; O WESTPHAL; O LUDERITZ; E A GORZYNSKI; E EICHENBERGER
Journal:  J Immunol       Date:  1956-05       Impact factor: 5.422

2.  Polyribophosphate, the type-specific substance of Hemophilus influenzae, type b.

Authors:  S ZAMENHOF; G LEIDY; P L FITZGERALD; H E ALEXANDER; E CHARGAFF
Journal:  J Biol Chem       Date:  1953-08       Impact factor: 5.157

3.  Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies.

Authors:  J B Robbins; J C Parke; R Schneerson; J K Whisnant
Journal:  Pediatr Res       Date:  1973-03       Impact factor: 3.756

4.  Differential effects on immunogenicity and antigenicity of heat, freezing and alkali treatment of bacterial antigens.

Authors:  H Y Whang; H Mayer; E Neter
Journal:  J Immunol       Date:  1971-06       Impact factor: 5.422

5.  Heteroimmunization to the capsular polysaccharide of Haemophilus influenzae type b induced by enteric cross-reacting bacteria.

Authors:  Z T Handzel; M Argaman; J C Parke; R Schneerson; J B Robbins
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

6.  Polyribitol-phosphate: an antigen of four gram-positive bacteria cross-reactive with the capsular polysaccharide of haemophilus influenzae type B.

Authors:  M Argaman; T Y Liu; J B Robbins
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

7.  Gel precipitation of common enterobacterial antigen by its antibody.

Authors:  H Y Whang; U Loza; E Neter; F Milgrom
Journal:  Int Arch Allergy Appl Immunol       Date:  1973

8.  Synthesis and release of polyribophosphate by Haemophilus influenzae type b in vitro.

Authors:  P Anderson; J Pitt; D H Smith
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

9.  Meningitis due to two serotypes of Escherichia coli. An infant who recovered.

Authors:  R I Goldenberg; E Neter
Journal:  Am J Dis Child       Date:  1977-02

10.  Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b.

Authors:  P Anderson; G Peter; R B Johnston; L H Wetterlow; D H Smith
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.